Recombinant Human FGF-8a Protein, CF Summary
Product Specifications
Gln23-Arg204, with an N-terminal Met
Analysis
Product Datasheets
Carrier Free
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
4745-F8
Formulation | Lyophilized from a 0.2 μm filtered solution in MOPS, Na2SO4, and EDTA. |
Reconstitution | Reconstitute at 500 μg/mL in sterile PBS. |
Shipping | The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below. |
Stability & Storage: |
|
Scientific Data
Recombinant Human FGF-8a (Catalog # 4745-F8) stimulates cell proliferation of the NR6R‑3T3 mouse fibroblast cell line. The ED50 for this effect is 0.25-1.5 μg/mL in the presence of 10 μg/mL heparin.
1 μg/lane of Recombinant Human FGF-8a was resolved with SDS-PAGE under reducing (R) conditions and visualized by silver staining, showing a single band at 22 kDa.
Reconstitution Calculator
Background: FGF-8
FGF-8 is a member of the fibroblast growth factor family that was originally discovered as a growth factor essential for the androgen-dependent growth of mouse mammary carcinoma cells (1-4). Alternate splicing of mouse FGF-8 mRNA generates eight secreted isoforms, designated a-h. Only FGF-8a, b, e and f exist in humans (4). FGF-8 contains a 22 amino acid (aa) signal sequence, an N-terminal domain that varies according to the isoform (20 aa for FGF-8a, which is the shortest), a 125 aa FGF domain and a 37 aa proline-rich C-terminal sequence. The FGF domain of FGF-8 shares the most aa identity with FGF17 (75%) and FGF-18 (67%), and the three form an FGF subfamily (2). Human FGF-8a shares 100% aa identity with mouse, rat and bovine FGF-8a, and 99%, 83%, 83% and 78% aa identity with canine, Xenopus, chicken and zebrafish FGF-8a, respectively. FGF-8 is widely expressed during embryogenesis, and mediates epithelial-mesenchymal transitions. It plays an organizing and inducing role during gastrulation, and regulates patterning of the midbrain/hindbrain, eye, ear, limbs and heart in the embryo (2, 5-8). The isoforms may play different roles in development. For example, FGF-8a expands the midbrain in transgenic mice, while FGF-8b transforms midbrain into cerebellum (5). FGF-8 activates the ‘c’ splice forms of fibroblast growth factor receptors FGF R2, FGF R3, and FGF R4, with differential activity among the FGF-8 isoforms (2, 9). FGF-8b shows the strongest receptor affinity and oncogenic transforming capacity, although FGF-8a and e are also transforming and have been found in human prostate, breast or ovarian tumors (1, 5, 10 - 13). FGF-8 shows limited expression in the normal adult, but low levels are found in the reproductive and genitourinary tract, peripheral leukocytes and bone marrow hematopoietic cells (3, 10, 14).
- Mattila, M.M. and P.L. Harkonen (2007) Cytokine Growth Factor Rev. 18:257.
- Reuss, B. and O. von Bohlen und Halbach (2003) Cell Tissue Res. 313:139.
- Payson, R.A. et al. (1996) Oncogene 13:47.
- Gemel, J. et al. (1996) Genomics 35:253.
- Olsen, S.K. et al. (2006) Genes Dev. 20:185.
- Crossley, P.H. et al. (1996) Cell, 84:127.
- Heikinheimo, M. et al. (1994) Mech. Dev. 48:129.
- Sun, X. et al. (1999) Genes Dev. 13:1834.
- Blunt, A.G. et al. (1997) J. Biol. Chem. 272:3733.
- Ghosh, A.K. et al. (1996) Cell Growth Differ. 7:1425.
- Mattila, M.M. et al. (2001) Oncogene 20:2791.
- Valve, E. et al. (2000) Int. J. Cancer 88:718.
- Valve, E.M. et al. (2001) Lab. Invest. 81:815.
- Nezu, M. et al. (2005) Biochem. Biophys. Res. Commun. 335:843.
Citations for Recombinant Human FGF-8a Protein, CF
R&D Systems personnel manually curate a database that contains references using R&D Systems products. The data collected includes not only links to publications in PubMed, but also provides information about sample types, species, and experimental conditions.
12
Citations: Showing 1 - 10
Filter your results:
Filter by:
-
A mitochondrial inside-out iron-calcium signal reveals drug targets for Parkinson's disease
Authors: Bharat, V;Durairaj, AS;Vanhauwaert, R;Li, L;Muir, CM;Chandra, S;Kwak, CS;Le Guen, Y;Nandakishore, P;Hsieh, CH;Rensi, SE;Altman, RB;Greicius, MD;Feng, L;Wang, X;
Cell reports
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Identification of ASCL1 as a determinant for human iPSC-derived dopaminergic neurons
Authors: AM Earley, LF Burbulla, D Krainc, R Awatramani
Scientific Reports, 2021-11-15;11(1):22257.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Defective metabolic programming impairs early neuronal morphogenesis in neural cultures and an organoid model of Leigh syndrome
Authors: G Inak, A Rybak-Wolf, P Lisowski, TM Pentimalli, R Jüttner, P Glažar, K Uppal, E Bottani, D Brunetti, C Secker, A Zink, D Meierhofer, MT Henke, M Dey, U Ciptasari, B Mlody, T Hahn, M Berruezo-L, N Karaiskos, M Di Virgili, JA Mayr, SB Wortmann, J Priller, M Gotthardt, DP Jones, E Mayatepek, W Stenzel, S Diecke, R Kühn, EE Wanker, N Rajewsky, M Schuelke, A Prigione
Nature Communications, 2021-03-26;12(1):1929.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Single-Cell Transcriptomics of Parkinson's Disease Human In�Vitro Models Reveals Dopamine Neuron-Specific Stress Responses
Authors: HJR Fernandes, N Patikas, S Foskolou, SF Field, JE Park, ML Byrne, AR Bassett, E Metzakopia
Cell Rep, 2020-10-13;33(2):108263.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Defects in mRNA Translation in LRRK2-Mutant hiPSC-Derived Dopaminergic Neurons Lead to Dysregulated Calcium Homeostasis
Authors: JW Kim, X Yin, A Jhaldiyal, MR Khan, I Martin, Z Xie, T Perez-Rose, M Kumar, L Abalde-Atr, J Xu, L Chen, SM Eacker, DJ Surmeier, NT Ingolia, TM Dawson, VL Dawson
Cell Stem Cell, 2020-08-25;27(4):633-645.e7.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
A monolayer hiPSC culture system for autophagy/mitophagy studies in human dopaminergic neurons
Authors: P Stathakos, N Jiménez-Mo, LA Crompton, PA Nistor, JL Badger, PA Barbuti, TL Kerrigan, AD Randall, MA Caldwell, JD Lane
Autophagy, 2020-04-14;0(0):1-17.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Fibroblast growth factor 8b induces uncoupling protein 1 expression in epididymal white preadipocytes
Authors: S Westphal, T Gantert, C Kless, K Hüttinger, M Klingenspo, T Fromme
Sci Rep, 2019-06-11;9(1):8470.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Felodipine induces autophagy in mouse brains with pharmacokinetics amenable to repurposing
Authors: FH Siddiqi, FM Menzies, A Lopez, E Stamatakou, C Karabiyik, R Ureshino, T Ricketts, M Jimenez-Sa, MA Esteban, L Lai, MD Tortorella, Z Luo, H Liu, E Metzakopia, HJR Fernandes, A Bassett, E Karran, BL Miller, A Fleming, DC Rubinsztei
Nat Commun, 2019-04-18;10(1):1817.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Human iPSC-Derived Neural Progenitors Are an Effective Drug Discovery Model for Neurological mtDNA Disorders
Authors: C Lorenz, P Lesimple, R Bukowiecki, A Zink, G Inak, B Mlody, M Singh, M Semtner, N Mah, K Aur‚, M Leong, O Zabiegalov, EM Lyras, V Pfiffer, B Fauler, J Eichhorst, B Wiesner, N Huebner, J Priller, T Mielke, D Meierhofer, Z Izsv k, JC Meier, F Bouillaud, J Adjaye, M Schuelke, EE Wanker, A LombŠs, A Prigione
Cell Stem Cell, 2017-01-26;0(0):.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Physiological characterisation of human iPS-derived dopaminergic neurons.
Authors: Hartfield, Elizabet, Yamasaki-Mann, Michiko, Ribeiro Fernandes, Hugo J, Vowles, Jane, James, William, Cowley, Sally A, Wade-Martins, Richard
PLoS ONE, 2014-02-21;9(2):e87388.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Altered splicing of FGFR1 is associated with high tumor grade and stage and leads to increased sensitivity to FGF1 in bladder cancer.
Authors: Tomlinson DC, Knowles MA
Am. J. Pathol., 2010-10-01;177(5):2379-86.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay -
Similar expression to FGF (Sef) inhibits fibroblast growth factor-induced tumourigenic behaviour in prostate cancer cells and is downregulated in aggressive clinical disease.
Authors: Darby S, Murphy T, Thomas H, Robson CN, Leung HY, Mathers ME, Gnanapragasam VJ
Br. J. Cancer, 2009-11-03;101(11):1891-9.
Species: Human
Sample Types: Whole Cells
Applications: Bioassay
FAQs
No product specific FAQs exist for this product, however you may
View all Proteins and Enzyme FAQsReviews for Recombinant Human FGF-8a Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Human FGF-8a Protein, CF and earn rewards!
Have you used Recombinant Human FGF-8a Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image